Abstract
INTRODUCTION
Human intestinal fl ora contains as many as 10 14 bacteria classifi ed into 400-500 species, which are ten times higher than all the cells in the human body. Some bacteria of the intestinal flora such as Clostridia, Proteus and Pseudomonas aeruginosa can be harmful, while others like bifi dobacteria and Lactobacilli belonging to the so-called probiotic strains are favorable for the organism. The microflora in the large intestine plays an important part in the life of the host organism [1, 2] . Its composition may change several times during our life. However it can still be regarded as nearly constant. Non-pathogenic, pathogenic and potentially pathogenic microorganisms living in a state of equilibrium determined by their own ecosystem within the large intestine take part in the local immunological and metabolic processes as well as in those affecting the organism as a whole [3, 4] . Some strains produce metabolites, such as short chain fatty acids and bactericins, which are of antibacterial effects. As a consequence of the relationship between cells of the mucous membrane and the microfl ora, the expression of certain mucosal genes may change, the cytokin release may increase, the proliferation of mucous membrane may change and produce a signifi cant effect on the intestine-associated lymphoid tissue which is the largest immune organ of the organism containing 80% of cells producing antibodies [5] [6] [7] [8] [9] . Certain strains of bacteria are capable of improving the barrier function of the mucous membrane and increase the differentiation of B cells as well as IgA secretion [4, 6] . The increasinfg data raise the idea of enriching foods with probiotics, prebiotics and symbiotic, a mixture of these two. Probiotics which are benefi cial non-pathogenic bacteria live in the intestinal canal and play a role in the preservation of health [10, 11] . The majority of prebiotics are oligosaccharides, i.e. the indigestible constituents of our plant food, which promote the multiplication, growth and effi cacy of the strains of probiotic bacteria in the large intestine. Nowadays several strains of probiotic bacteria are known, but their utilization is restricted by the fact that an effective probiotic is supposed to proceed along the acidy pH of the stomach and is able to resist the digestion of bile and pancreatic juice and fi nally sticks to the surface of some cells in the intestinal wall. The lifespan of the stuck probiotic is short, ranging from a few days to a few weeks and it usually lasts for a short period of time following its regular intake. Colonizing probiotics compete with other microrganisms for nutrients and appropriate binding sites. Only probiotics capable of colonizing even if only temporarily, can exert the required immunological effect [1, 7, 8] .
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The in vitro efficacy of the well-known probiotic strains has already been proved in clinical practice 12] . The most widely used strains are those taken from sour dairy products and the intestinal system. The most frequently studied species include various species of Lactobacilli, Streptococcus, thermophilus, bifi dobacteria, Saccharomyces boulardii, but under certain conditions other strains in the intestinal microfl ora, such as Escherichia coli (E. coli) can also be used as probiotics [13, 14] . In order to become suitable for producing health improving foods, namely functional foods, individual probiotic strains need to meet certain requirements [15, 16] . The following criteria are listed for effective probiotic bacteria [17, 18] : maintenance of the biotic potential, good taste and fl avor following fermentation, mild acidity in the course of storage, preservation of the capability of colonizing in the course of food technology and storage, high degree of stability during storage, stability in the course of freeze-drying or other drying procedures, accurate and reliable determination of the strain, and the dose-dependent effects Biofi r ® is a traditional, so-called Russian type of kefi r based on probiotic lactic acid bacteria culture composed of termophilic strains (producing exopolysacharides) developed by the Hungarian Dairy Research Institute. The present study was undertaken to investigate the effect of a four-week-long consumption of Biofi r ® on the faecal microfl ora.
MATERIALS AND METHODS

Patients
One hundred and twenty healthy volunteers (71 females and 49 males) were included in the study following the permission of the Ethical Committee. Their age ranged from 18 to 59 years. The basic selection criterion was that no antibiotics were taken by the subjects 2 mo prior to the investigation. (Table 1 Prior to the investigation, blood, urine and faece samples were taken from the subjects for routine laboratory analysis and faecal microfl ora examination. The investigations lasted for 6 wk, while the subjects followed standard diet which was free of sour dairy products and other probiotic foods. The diet was controlled regularly by the dietitian. Then the control group (60 persons) consumed 0.5 L of Russian type kefi r daily for four week, while those included in the study group (60 persons) consumed a daily amount of 0.5 L of probiotic kefi r.
Composition of kefi rs
Faece samples were taken in the 2 nd , 4 th and 6 th weeks. The screening type of blood sample analysis was repeated in the 4 th wk. Faece samples were stored in sterile containers at 4 °C and sent to the Hungarian Dairy Research Institute in 4-6 h, where determination of the various germ groups was carried out in internationally accepted cultures. In addition to the analysis of the microfl ora, the pH value of the faeces was also determined ( Table 2) .
Statistical analysis
Evaluation of the data included calculation of the changes in percentage. Determination of the differences with regard to the self-control was carried out using one sample T probe, while two-sample T probes were used for the comparison of the two groups.
RESULTS
The essential question in the course of analyzing the faecal microfl ora was how the consumption of each type of kefi r infl uenced the number of primary probiotic Streptococci, Lactobacilli and bifi dobacteria within the total number of germs.
The effect of the tested dairy products on the essential faecal microfl ora during the 4-wk clinical investigation is listed in Table 3 .
The results indicated that the number of all microbes increased 4.3-fold in the control group consuming the traditional Russian type of kefi r and 6.8-fold in the group consuming the probiotic Biofi r ® , respectively after 4 wk. A very important difference was found between the two groups. The rate of probiotic microbes decreased from 8.9% to 2.7% in the control group by the end of the 4 th wk and increased from 12.7% to 72% in the target group. Within the total number of the probiotic germs, the greatest increase (59.7-fold) resulting from the consumption of Biofi r ® could be observed in bifi dobacteria, a lower increase (6.8 fold) was found in Streptococci, while the index of Lactobacilli showed no change. No signifi cant change was found in faece pH values in both groups. The participants followed the prescribed diet but consumed no probiotic food for another two weeks following the 4-wk period of consumption. Microfl ora analysis of the faeces was repeated in the 6th wk. The results indicated that both the total number of germs and the number of probiotic germs returned to the initial values in both groups.
DISCUSSION
Various types of medical treatment may damage the probiotic fl ora in human organ. Besides, similar damage can result from the lack of appropriate nutrients in the normal flora. The findings of several controlled studies in the fi eld have proved that various probiotic strains are capable of shortening the duration of gastroenteritis induced by rotavirus. The benefi cial effects of probiotics on chronic inflammatory intestinal conditions have been reported. These effects may be attributed to the proteolytic activity of the intestinal fl ora, which contributes to the breaking up of enteral antigens, reduces secretion of inflammation mediators, helps the normal activity of the intestinal mucosal barrier, normalizes intestinal permeability and increases the production of mucosal IgA [19] [20] [21] . The production of specifi c IgE, which prevents the allergic reactions, is inhibited by the healthy intestinal microfl ora [19, 22] . A well-known probiotic effect is that some bacteria produce beta galactozidase, which makes their use desirable and benefi cial in the case of lactose intolerance. The decreased activity of faecal enzymes and the low levels of faecal toxins are due to the healthy intestinal fl ora, which is an important factor for the prevention of large intestine cancer.
Prebiotics play an important part in the maintenance and regeneration of healthy intestinal flora as they are components of several plant foods and oligosaccharides with benefi cial effect on the host organisms by selectively increasing the multiplication of probiotic bacteria and their activity in the large intestine.
One of the probiotic strains of bacteria used in the present study is capable of producing mucus. The mucus produced by it is a polysaccharide, which serves as a prebiotic agent for other probiotic strains. Besides, it increases the preservability of food products containing it and prevents their acidifi cation.
The present study proved that Biofi r ® , a probiotic kefi r, was capable of promoting the multiplication of the probiotic fl ora in the large intestine but the traditional Russian type kefi r could not. As a result of the consumption of Biofi r ® most probiotic microbes grew signifi cantly but the consumption of traditional kefi r did not change the number (index) of these microbes.
In the present study, the initial heterogeneous color and the consistency of faecal samples were totally homogenuous after four weeks of Biofi r ® consumption, probably due to the advantageous bio-physiological processes caused by the multiplication and ultimate predominance of the useful probiotic microbes.
In conclusion, Biofi r ® meets all the criteria of functional foods and can be used in the prevention and treatment of various acute and chronic inflammatory conditions and nutritional allergies. Further investigations should be Table 3 Effect of consumption of tested dairy products on the essential microfl ora in 4-wk clinical investigation
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